ArticleAnnals of the rheumatic diseases2008

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.

C A Wijbrandts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.